NEW YORK (GenomeWeb) – Device firm EKF Diagnostics said that it is considering plans to split into two separate companies — one focused on point-of-care testing and the other on laboratory diagnostics.

As part of this plan, the company said it would delist its shares from the AIM market and seek listings for each new company separately in a market to be determined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.